TY - JOUR T1 - Radioiodine therapy in patient of differentiated thyroid cancer with end-stage renal disease on maintenance hemodialysis: case report with review of literature. JF - Journal of Nuclear Medicine Technology JO - J. Nucl. Med. Technol. DO - 10.2967/jnmt.121.261979 SP - jnmt.121.261979 AU - Munish Kumar AU - Karthikeyan Subramanian AU - Karan Singh Tanwar AU - Arun Prabhahar AU - Smita Divyaveer AU - Ashwani Sood AU - Bhagwant Rai Mittal AU - Apurva Sood Y1 - 2021/12/01 UR - http://tech.snmjournals.org/content/early/2021/12/06/jnmt.121.261979.abstract N2 - Surgical resection followed by radioactive-iodine (131I) therapy constitutes a standard treatment for differentiated thyroid cancer (DTC). 131I is normally excreted through kidneys and treatment of patients with end stage renal disease (ESRD) on hemodialysis requires special attention for dosage of 131I, timing of dialysis and radiation safety. We present a case of a post-thyroidectomy patient with ESRD on haemodialysis who required radioactive iodine ablation with review of literature. ER -